The effect of alcohol ingestion on exhaled nitric oxide.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 8804927)

Published in Eur Respir J on June 01, 1996

Authors

D H Yates1, S A Kharitonov, R A Robbins, P S Thomas, P J Barnes

Author Affiliations

1: Dept of Thoracic Medicine, National Heart & Lung Institute, London, UK.

Articles by these authors

Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70

Hybridization of denatured RNA transferred or dotted nitrocellulose paper. Methods Enzymol (1983) 14.71

Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48

Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med (1996) 5.53

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med (2001) 5.47

Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39

Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25

Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24

Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) (1998) 4.31

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial. Lancet (2001) 3.48

Chicken soup inhibits neutrophil chemotaxis in vitro. Chest (2000) 3.48

Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med (1999) 3.44

Asthma as an axon reflex. Lancet (1986) 3.26

Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet (1982) 3.21

Exhaled markers of pulmonary disease. Am J Respir Crit Care Med (2001) 3.14

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol (2000) 3.13

Neural control of human airways in health and disease. Am Rev Respir Dis (1986) 2.97

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework. Lancet (2000) 2.87

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J (1997) 2.79

Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med (1997) 2.77

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax (1998) 2.71

Exacerbations of chronic obstructive pulmonary disease. Eur Respir J (2007) 2.65

Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis (1987) 2.64

Cytokines in asthma. Thorax (1999) 2.64

Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet (1986) 2.41

Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med (2000) 2.33

Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med (1996) 2.32

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med (1992) 2.32

Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 2.28

Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22

Exhaled carbon monoxide in childhood asthma. J Pediatr (1999) 2.19

Activation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med (1998) 2.19

Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J (2001) 2.18

Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J (2004) 2.18

Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun (1993) 2.14

Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med (1997) 2.12

STAT4 activation in smokers and patients with chronic obstructive pulmonary disease. Eur Respir J (2004) 2.06

Rachitic respiratory distress in small preterm infants. Arch Dis Child (1977) 2.04

Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J (2002) 2.04

Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med (2000) 2.03

Severe lumbar back pain following epidural injection of local anesthetic for epidural anesthesia. Case report and literature review. Reg Anesth (1995) 2.01

The effect of airway epithelium on smooth muscle contractility in bovine trachea. Br J Pharmacol (1985) 1.98

Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun (2004) 1.98

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96

Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun (1994) 1.96

Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.94

Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med (1999) 1.92

Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med (1997) 1.91

A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax (1981) 1.90

Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis (1985) 1.89

T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol (2009) 1.89

Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J (1998) 1.86

Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med (1995) 1.84

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med (1997) 1.84

Duodenal ulcer in children. Arch Dis Child (1972) 1.84

Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med (2001) 1.82

Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol (1994) 1.82

Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J (1995) 1.80

Brittle asthma. Thorax (1998) 1.77

Importance of inhaler devices in the management of airway disease. Respir Med (2007) 1.76

Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax (2001) 1.76

Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med (2000) 1.75

Circulating catecholamines in acute asthma. Br Med J (Clin Res Ed) (1985) 1.73

Is immunotherapy for asthma worthwhile? N Engl J Med (1996) 1.72

Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res (2000) 1.72

Quality of life in ALS depends on factors other than strength and physical function. Neurology (2000) 1.70

Neutrophil chemotactic factors in bacterial pneumonia. Chest (1989) 1.69

Effect of inhaled corticosteroids on bones and growth. Eur Respir J (1998) 1.68

Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax (2004) 1.68

Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. Eur Respir J (2003) 1.68

Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med (1995) 1.67

Pseudo-steroid resistant asthma. Thorax (1999) 1.67

Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol (1992) 1.67

Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med (1995) 1.67

Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. J Allergy Clin Immunol (1997) 1.65

Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med (1998) 1.65

Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med (1996) 1.65

Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65

Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax (2009) 1.65

Specific measurement of DNA in nuclei and nucleic acids using diaminobenzoic acid. Anal Biochem (1978) 1.64

Exhaled nitric oxide: a new lung function test. Thorax (1996) 1.64

Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun (1997) 1.63

Adenosine as a vasodilator in primary pulmonary hypertension. Circulation (1991) 1.63

Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med (2001) 1.63

Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax (1998) 1.63

Caffeine decreases exhaled nitric oxide. Thorax (2002) 1.62

Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax (2008) 1.62

Bronchoconstrictor response to inhaled capsaicin in humans. J Appl Physiol (1985) (1985) 1.61